Your browser is no longer supported. Please, upgrade your browser.
Settings
RMD ResMed Inc. daily Stock Chart
RMD [NYSE]
ResMed Inc.
IndexS&P 500 P/E35.70 EPS (ttm)3.29 Insider Own0.70% Shs Outstand143.22M Perf Week1.75%
Market Cap16.82B Forward P/E28.29 EPS next Y4.15 Insider Trans-6.79% Shs Float140.75M Perf Month6.00%
Income473.70M PEG4.68 EPS next Q0.94 Inst Own68.20% Short Float2.18% Perf Quarter10.75%
Sales2.40B P/S6.99 EPS this Y31.10% Inst Trans0.31% Short Ratio3.31 Perf Half Y8.19%
Book/sh13.32 P/B8.81 EPS next Y12.28% ROA10.10% Target Price108.13 Perf Year32.32%
Cash/sh1.61 P/C73.05 EPS next 5Y7.62% ROE16.70% 52W Range87.10 - 118.13 Perf YTD3.11%
Dividend1.48 P/FCF67.97 EPS past 5Y8.50% ROI19.80% 52W High-0.61% Beta0.80
Dividend %1.26% Quick Ratio1.90 Sales past 5Y9.10% Gross Margin58.20% 52W Low34.80% ATR2.81
Employees5940 Current Ratio2.60 Sales Q/Q12.30% Oper. Margin23.80% RSI (14)62.61 Volatility1.49% 2.63%
OptionableYes Debt/Eq0.28 EPS Q/Q22.90% Profit Margin13.90% Rel Volume0.64 Prev Close116.89
ShortableYes LT Debt/Eq0.27 EarningsJan 24 AMC Payout60.50% Avg Volume926.05K Price117.41
Recom2.50 SMA205.37% SMA507.45% SMA20010.38% Volume775,605 Change0.44%
Oct-26-18Upgrade Credit Suisse Neutral → Outperform
Jul-02-18Initiated Goldman Buy
Apr-04-18Downgrade Citigroup Buy → Neutral
Jan-23-18Upgrade Northland Capital Under Perform → Market Perform
Jan-23-18Upgrade Needham Underperform → Hold
Sep-25-17Reiterated Barclays Underweight $65 → $68
Aug-02-17Upgrade Citigroup Neutral → Buy
Aug-02-17Downgrade Credit Suisse Outperform → Neutral
Aug-02-17Downgrade BofA/Merrill Buy → Neutral
Apr-28-17Downgrade Citigroup Buy → Neutral
Jan-24-17Upgrade JP Morgan Neutral → Overweight
Jan-24-17Reiterated Canaccord Genuity Hold $55 → $59
Oct-04-16Initiated JP Morgan Neutral $64
Aug-23-16Downgrade Jefferies Hold → Underperform
Jun-27-16Downgrade Needham Hold → Underperform
Apr-28-16Upgrade Macquarie Underperform → Neutral
Apr-27-16Downgrade Piper Jaffray Overweight → Neutral
Apr-07-16Resumed Barclays Underweight $55
Jan-22-16Upgrade Credit Suisse Neutral → Outperform
Jan-19-16Downgrade Barclays Equal Weight → Underweight $61 → $52
Jan-17-19 10:31AM  Analysts Estimate ResMed (RMD) to Report a Decline in Earnings: What to Look Out for Zacks
Jan-16-19 07:30AM  New Research Coverage Highlights Gentex, Tenneco, Mercury General, MGM Resorts International, ResMed, and Alnylam Pharmaceuticals Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Jan-09-19 08:03AM  At US$114, Is It Time To Put ResMed Inc. (NYSE:RMD) On Your Watch List? Simply Wall St.
07:36AM  ResMed Announces Complete Mobi Launch in US Markets for COPD Zacks
Jan-08-19 09:05AM  Mobi Is Here: ResMeds First Portable Oxygen Device Now Widely Available in the U.S. Business Wire
09:01AM  ResMed Closes Propeller Health Buyout, Boosts COPD Suite Zacks
Jan-07-19 04:30PM  Safeguard Scientifics Partner Company Propeller Health Acquired By ResMed PR Newswire
04:05PM  ResMed Completes $225 Million Acquisition of Propeller Health Business Wire
Jan-03-19 04:05PM  ResMed to Report Second Quarter Fiscal 2019 Earnings on January 24, 2019 Business Wire
Dec-29-18 09:57AM  Stock Market Forecast For 2019: 7 Critical Trends To Watch Investor's Business Daily
Dec-28-18 04:26PM  These 5 Tech Companies Strut Rising Relative Strength Amid Bear Market Investor's Business Daily
Dec-24-18 03:14PM  IBD 50 Growth Stocks To Watch: This Sleep-Care Play Has Some Things Going For It Investor's Business Daily
Dec-20-18 08:40AM  Inogen Gains From Commercial Launch of Wireless Connect Zacks
06:56AM  Need To Know: ResMed Inc. (NYSE:RMD) Insiders Have Been Selling Shares Simply Wall St.
Dec-17-18 09:05AM  Brightree Acquires Mobile Delivery Provider Apacheta to Streamline HME Delivery Business Wire
Dec-12-18 02:57AM  Do Hedge Funds Love ResMed Inc. (RMD)? Insider Monkey
Dec-07-18 08:10AM  Detailed Research: Economic Perspectives on ResMed, Proofpoint, Southwestern Energy, Knowles, Chipotle Mexican Grill, and Medtronic What Drives Growth in Today's Competitive Landscape GlobeNewswire
Dec-06-18 08:56AM  ResMed to Buy Propeller Health, Widens Respiratory Care Suite Zacks
Dec-03-18 12:28PM  Propeller Health's $225M exit means Safeguard will net $41M American City Business Journals
11:06AM  Madison's Propeller Health being sold for $225M to San Diego firm American City Business Journals
09:44AM  What You Must Know About ResMed Incs (NYSE:RMD) Financial Health Simply Wall St.
09:15AM  Safeguard Scientifics Partner Company Propeller Health To Be Acquired For $225 Million By ResMed PR Newswire
09:05AM  ResMed to Acquire Propeller Health, a Leader in COPD and Asthma Connected Health Solutions, for $225 Million Business Wire
Nov-20-18 09:05AM  ResMed Elects Harjit Gill to Its Board of Directors Business Wire
Nov-15-18 09:40AM  ResMed (RMD) Closes MatrixCare Buyout, Boosts SaaS Line Zacks
Nov-14-18 09:05AM  ResMed Completes Acquisition of MatrixCare Business Wire
Nov-13-18 09:02AM  Is ResMed Incs (NYSE:RMD) CEO Incentives Align With Yours? Simply Wall St.
Nov-07-18 10:54AM  ResMed's Out-of-Hospital Line to Grow With MatrixCare Buyout Zacks
Nov-05-18 09:05AM  ResMed to Acquire MatrixCare, Expands Out-of-Hospital SaaS Portfolio into Long-Term Care Settings Business Wire
Oct-30-18 07:55AM  Research Report Identifies Charter Communications, Old Dominion Freight Line, CoreLogic, Align Technology, HealthStream, and ResMed with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Oct-29-18 08:59AM  ResMed (RMD) Looks Good: Stock Adds 5.7% in Session Zacks
Oct-26-18 02:46PM  ResMed Starts Its Fiscal Year Strong Motley Fool +5.69%
02:00PM  Edited Transcript of RMD earnings conference call or presentation 25-Oct-18 8:30pm GMT Thomson Reuters StreetEvents
09:24AM  ResMed (RMD) Q1 Earnings & Sales Beat on Overall Growth Zacks
04:31AM  ResMed Inc (RMD) Q1 2019 Earnings Conference Call Transcript Motley Fool
Oct-25-18 06:14PM  How ResMed is benefiting from ageing demographics CNBC Videos
05:20PM  ResMed (RMD) Q1 Earnings and Revenues Surpass Estimates Zacks
04:13PM  ResMed: Fiscal 1Q Earnings Snapshot Associated Press
04:05PM  ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2019 Business Wire
Oct-24-18 08:38AM  Could The ResMed Inc (NYSE:RMD) Ownership Structure Tell Us Something Useful? Simply Wall St.
08:38AM  Medical Product Earnings Lineup for Oct 25: SYK, CERN & More Zacks
Oct-22-18 04:30PM  ResMed Wins German Patent Infringement Case Against Fisher & Paykel Business Wire
Oct-16-18 09:05AM  Brightree Launches First Patient App for HME Business Wire
08:57AM  Does ResMed Incs (NYSE:RMD) Past Performance Indicate A Weaker Future? Simply Wall St.
Oct-15-18 09:05AM  AirFit F30, ResMeds First Minimal-Contact Full Face CPAP Mask, Now Available in the U.S., Canada Business Wire
Oct-05-18 08:04PM  USITC to investigate Resmed for alleged patent infringement Reuters
Oct-04-18 04:08PM  ResMed to Announce First Quarter Fiscal 2019 Results Business Wire
Sep-26-18 08:25AM  Should You Be Tempted To Buy ResMed Inc (NYSE:RMD) Because Of Its PE Ratio? Simply Wall St.
Sep-18-18 05:16PM  ResMed Unveils AirFit F30, Expands AirFit Mask Portfolio Zacks
09:05AM  175 Million Europeans Have Sleep Apnoea, Highlighting Scale of Global Health Crisis Business Wire
Sep-13-18 08:00AM  ResMed Introduces Its First Minimal-contact Full Face CPAP Mask, AirFit F30 Business Wire
Sep-11-18 11:44AM  5 Companies Hit 52-Week Highs GuruFocus.com
Sep-10-18 06:06PM  NZ's Fisher & Paykel Healthcare files complaint in the U.S. against Resmed Reuters
05:41PM  NZ's Fisher & Paykel Healthcare files patent infringement complaint against ResMed Reuters
Sep-02-18 05:19PM  NZ's Fisher & Paykel cuts FY guidance on ResMed-linked legal costs Reuters
04:58PM  NZ's Fisher & Paykel Healthcare cuts FY guidance on higher expected legal costs Reuters
Aug-31-18 04:05PM  ResMed Files Patent Infringement Action against Fisher & Paykel Business Wire
Aug-27-18 09:19AM  Tap the Sleep Apnea Devices Market Boom With These 3 Stocks Zacks
09:05AM  ResMeds Astral Life Support Ventilator Now Has AutoEPAP in U.S. Business Wire
Aug-17-18 06:48PM  ResMed Inc (RMD) Files 10-K for the Fiscal Year Ended on June 30, 2018 GuruFocus.com
Aug-14-18 11:34AM  What Do Analysts Think About ResMed Incs (NYSE:RMD) Growth? Simply Wall St.
Aug-03-18 07:35PM  Edited Transcript of RMD earnings conference call or presentation 2-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
04:48PM  ResMed Bumps Its Dividend Payment After a Solid End to Its Fiscal Year Motley Fool
10:07AM  ResMed (RMD) Q4 Earnings & Sales Beat on Overall Growth Zacks
Aug-02-18 07:10PM  ResMed (RMD) Q4 Earnings and Revenues Top Estimates Zacks
06:38PM  President of ResMed on the outlook of his company CNBC Videos
06:15PM  ResMed: Fiscal 4Q Earnings Snapshot Associated Press
04:05PM  ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2018 Business Wire
Aug-01-18 08:30AM  Why Earnings Season Could Be Great for ResMed (RMD) Zacks
08:20AM  Medical Product Earnings Lineup for Aug 2: ABC, BDX & More Zacks
Jul-23-18 11:31AM  Can Overall Growth Drive ResMed's (RMD) Q4 Earnings? Zacks
Jul-20-18 07:25AM  Free Pre-Market Technical Recap on ResMed and Three Additional Healthcare Stocks ACCESSWIRE
Jul-12-18 09:58AM  Alphabet (GOOGL) to Form JV With ResMed to Treat Sleep Apnea Zacks
Jul-11-18 07:51PM  Alphabet and ResMed are spinning out a start-up to solve sleep apnea, a hidden health crisis CNBC
11:41AM  Can Abbott (ABT) Rise on Robust Overall Growth in Q2 Earnings? Zacks
09:05AM  ResMed, Verily to Form Joint Venture to Help Reach Millions of Untreated Sleep Apnea Sufferers Business Wire
Jul-05-18 04:05PM  ResMed to Announce Fourth Quarter Fiscal Year 2018 Results Business Wire
Jun-18-18 10:30AM  ResMed Inks Deal With athenaHealth on Brightree's eReferral Zacks
08:30AM  Analysis: Positioning to Benefit within The Stars Group, AMAG Pharmaceuticals, ResMed, WestRock, Briggs & Stratton, and II-VI Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jun-14-18 09:05AM  Brightree Announces eReferral Integration with athenahealth Business Wire
Jun-08-18 07:40AM  Free Daily Technical Summary Reports on Tandem Diabetes Care and Three Other Medical Supplies Stocks ACCESSWIRE
Jun-07-18 09:17AM  ResMed Reports Positive Results for Bilevel PAP Device Study Zacks
Jun-04-18 09:05AM  New ResMed-sponsored Study Shows Switching to Bilevel PAP Saves 56% of Patients from Therapy Termination Business Wire
Jun-01-18 11:06AM  Illumina (ILMN) Grows on Innovation & Strategic Partnerships Zacks
May-31-18 07:00AM  Arcturus Announces Management Appointments; Company Founder Joseph E. Payne Reinstated as President and CEO GlobeNewswire
May-30-18 10:09AM  ResMed's (RMD) HEALTHCAREfirst Buyout to Boost SaaS Business Zacks
May-29-18 01:51PM  [$$] ResMed to Acquire Pamlico Capital's HealthcareFirst The Wall Street Journal
10:51AM  Here's Why You Should Add ResMed (RMD) to Your Portfolio Now Zacks
09:47AM  Top Ranked Momentum Stocks to Buy for May 29th Zacks
09:05AM  ResMed to Acquire HEALTHCAREfirst, a Cloud-based Software and Services Provider for Home Health and Hospice Agencies Business Wire
08:42AM  Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne GlobeNewswire
May-28-18 03:19AM  ResMed (RMD) Up 6.1% Since Earnings Report: Can It Continue? Zacks
May-22-18 10:34AM  3 Stocks for Baby Boomers to Reach Their Goals Motley Fool
08:55AM  ResMed Studies Show Remote Monitoring and Automated Resupply Improve Adherence to PAP Therapy Business Wire
May-21-18 02:15PM  Nearly 1 Billion People Worldwide Have Sleep Apnea, International Sleep Experts Estimate Business Wire
11:04AM  ResMed Releases Positive U.S. & U.K. Study Data on COPD Zacks
May-20-18 05:15PM  ResMed-sponsored Studies Show Combining Home Oxygen and Home Non-invasive Ventilation is a Cost Effective Treatment for COPD Business Wire
May-18-18 07:10AM  Free Post Earnings Research Report: ResMeds Revenue Jumped 15%; Adjusted EPS Surged 30% ACCESSWIRE
May-17-18 06:56AM  Companies including Symantec are using ghost revenue to calculate bonuses MarketWatch
May-16-18 07:38AM  Commercial Success Following FDA Clearance Could Indicate 250% or More In Upside for BTCY Shareholders ACCESSWIRE
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides humidifiers, carry bags, and breathing circuits; data communications and control products, such as AirView Diagnostics, EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules; U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; and myAir, a patient engagement application that provides sleep data and a daily score based on their previous night's data, as well as offers business management software and services to medical equipment and home health providers. It markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 120 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Douglas Robert AndrewPresident and COO ResMed Inc.Jan 15Option Exercise43.633,307144,28441,728Jan 16 04:25 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Jan 15Sale114.18881100,593155,332Jan 16 04:25 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Jan 15Sale114.183,307377,59338,421Jan 16 04:25 PM
Sandercock BrettChief Financial OfficerJan 15Sale114.182,000228,36094,390Jan 16 04:18 PM
Farrell Michael J.Chief Executive OfficerJan 14Option Exercise43.636,651290,183292,933Jan 16 04:06 PM
Farrell Michael J.Chief Executive OfficerJan 14Sale113.756,651756,551286,282Jan 16 04:06 PM
PENDARVIS DAVIDChief Administrative OfficerJan 03Option Exercise51.254,457228,421122,459Jan 04 03:48 PM
PENDARVIS DAVIDChief Administrative OfficerJan 03Sale110.824,457493,925118,002Jan 04 03:48 PM
Hollingshead JamesPresident, AmericasJan 02Option Exercise58.2480046,59284,489Jan 03 04:04 PM
Hollingshead JamesPresident, AmericasJan 02Sale112.131,600179,40882,889Jan 03 04:04 PM
Sandercock BrettChief Financial OfficerDec 31Sale112.503,000337,50096,390Jan 02 05:56 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Dec 17Option Exercise43.633,307144,28489,605Dec 18 07:15 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Dec 17Sale112.5688699,728108,336Dec 18 07:15 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Dec 17Sale112.563,307372,23686,298Dec 18 07:15 PM
Sandercock BrettChief Financial OfficerDec 17Sale112.562,000225,12099,390Dec 20 01:38 PM
PENDARVIS DAVIDChief Administrative OfficerDec 03Option Exercise51.254,455228,319122,457Dec 06 12:12 PM
Hollingshead JamesPresident, AmericasDec 03Sale112.0960067,25483,689Dec 06 12:11 PM
PENDARVIS DAVIDChief Administrative OfficerDec 03Sale112.094,455499,361118,002Dec 06 12:12 PM
Hollingshead JamesPresident, AmericasNov 30Option Exercise43.639,168400,00084,289Dec 03 12:07 PM
McHale RichardPresident, RC BusinessNov 30Sale111.561,800200,80823,507Dec 03 12:08 PM
Sandercock BrettChief Financial OfficerNov 30Sale110.503,000331,500101,390Dec 03 12:09 PM
Hollingshead JamesPresident, AmericasNov 27Sale105.525,893621,82975,121Nov 27 05:45 PM
Farrell Michael J.Chief Executive OfficerNov 16Sale104.493,300344,8170Nov 20 11:58 AM
Douglas Robert AndrewPresident and COO ResMed Inc.Nov 15Option Exercise43.633,307144,28459,112Nov 19 03:24 PM
Sandercock BrettChief Financial OfficerNov 15Sale101.442,000202,88072,156Nov 16 08:50 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Nov 15Sale101.4498499,817109,222Nov 19 03:24 PM
Douglas Robert AndrewPresident and COO ResMed Inc.Nov 15Sale101.443,307335,46255,805Nov 19 03:24 PM
PENDARVIS DAVIDChief Administrative OfficerNov 12Option Exercise58.241,71799,998105,753Nov 13 06:13 PM
PENDARVIS DAVIDChief Administrative OfficerNov 05Option Exercise38.982,810109,534109,982Nov 06 04:20 PM
PENDARVIS DAVIDChief Administrative OfficerNov 05Sale105.972,810297,776107,172Nov 06 04:20 PM
Hollingshead JamesPresident, Sleep BusinessNov 01Sale105.9360063,55873,304Nov 02 04:11 PM
Sandercock BrettChief Financial OfficerOct 15Sale103.162,000206,32071,232Oct 17 01:09 PM
PENDARVIS DAVIDChief Administrative OfficerOct 03Option Exercise38.982,810109,534107,061Oct 04 04:17 PM
PENDARVIS DAVIDChief Administrative OfficerOct 03Sale113.952,810320,200104,251Oct 04 04:17 PM
Hollingshead JamesPresident, Sleep BusinessOct 01Sale115.8860069,52870,623Oct 03 05:59 PM
Sandercock BrettChief Financial OfficerSep 17Sale114.302,000228,60073,232Sep 18 07:13 PM
PENDARVIS DAVIDChief Administrative OfficerSep 04Option Exercise38.982,810109,534107,061Sep 05 01:59 PM
PENDARVIS DAVIDChief Administrative OfficerSep 04Sale111.262,810312,641104,251Sep 05 01:59 PM
Hollingshead JamesPresident, Sleep BusinessSep 04Sale111.5960066,95471,223Sep 05 01:58 PM
Sandercock BrettChief Financial OfficerAug 15Sale107.452,000214,90063,072Aug 16 07:11 PM
PENDARVIS DAVIDChief Administrative OfficerAug 03Option Exercise38.982,810109,534101,893Aug 06 02:47 PM
PENDARVIS DAVIDChief Administrative OfficerAug 03Sale106.202,810298,42299,083Aug 06 02:47 PM
Hollingshead JamesPresident, Sleep BusinessAug 01Sale105.9360063,55859,663Aug 02 01:29 PM
Sandercock BrettChief Financial OfficerJul 16Sale109.012,000218,02065,072Jul 17 02:05 PM
PENDARVIS DAVIDChief Administrative OfficerJul 03Option Exercise38.982,810109,534101,893Jul 05 07:20 PM
PENDARVIS DAVIDChief Administrative OfficerJul 03Sale103.902,810291,95999,083Jul 05 07:20 PM
Hollingshead JamesPresident, Sleep BusinessJul 02Sale102.8060061,68060,263Jul 03 03:28 PM
Sandercock BrettChief Financial OfficerJun 15Sale106.762,000213,52067,072Jun 19 06:42 PM
PENDARVIS DAVIDChief Administrative OfficerJun 04Option Exercise38.982,810109,534101,893Jun 04 05:57 PM
PENDARVIS DAVIDChief Administrative OfficerJun 04Sale103.752,810291,53899,083Jun 04 05:57 PM
Hollingshead JamesPresident, Sleep BusinessJun 01Sale102.8060061,68060,863Jun 04 04:20 PM
SULPIZIO RICHARDDirectorMay 30Option Exercise27.5828,403783,35535,823Jun 01 12:18 PM
SULPIZIO RICHARDDirectorMay 30Sale102.7828,4032,919,2607,420Jun 01 12:18 PM
Sandercock BrettChief Financial OfficerMay 15Sale101.522,000203,04069,072May 16 08:47 PM
PACE GARY WDirectorMay 08Option Exercise27.5828,403783,355128,981May 10 07:07 AM
PACE GARY WDirectorMay 08Sale97.3728,4032,765,600100,578May 10 07:07 AM
PENDARVIS DAVIDChief Administrative OfficerMay 03Option Exercise46.316,683309,50599,106May 04 08:03 PM
PENDARVIS DAVIDChief Administrative OfficerMay 03Sale95.912,810269,50795,233May 04 08:03 PM
Hollingshead JamesPresident, Sleep BusinessMay 01Sale94.6960056,81461,261May 02 12:45 PM
Sandercock BrettChief Financial OfficerApr 16Sale99.362,000198,72071,072Apr 17 09:37 PM
PENDARVIS DAVIDChief Administrative OfficerApr 03Option Exercise38.982,810109,53497,263Apr 04 07:34 PM
PENDARVIS DAVIDChief Administrative OfficerApr 03Sale96.192,810270,29494,453Apr 04 07:34 PM
Hollingshead JamesPresident, Sleep BusinessApr 02Sale98.1960058,91459,940Apr 03 09:09 PM
Sandercock BrettChief Financial OfficerMar 15Sale98.532,000197,06073,072Mar 19 12:38 PM
PENDARVIS DAVIDChief Administrative OfficerMar 05Option Exercise38.982,810109,53497,263Mar 07 01:30 PM
PENDARVIS DAVIDChief Administrative OfficerMar 05Sale94.082,810264,36594,453Mar 07 01:30 PM
Hollingshead JamesPresident, Sleep BusinessMar 01Sale94.0160056,40660,540Mar 02 03:21 PM
Sandercock BrettChief Financial OfficerFeb 15Sale93.422,000186,84075,072Feb 16 08:27 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 05Option Exercise38.982,810109,53497,263Feb 06 01:14 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 05Sale96.032,810269,84494,453Feb 06 01:14 PM
Sandercock BrettChief Financial OfficerFeb 01Sale100.131,250125,16377,072Feb 02 05:16 PM
McHale RichardPresident, RC BusinessFeb 01Sale100.122,000200,24012,204Feb 05 01:02 PM
Hollingshead JamesPresident, Sleep BusinessFeb 01Sale100.1160060,06662,002Feb 05 01:01 PM
WAREHAM JOHN PDirectorJan 26Option Exercise38.9825,9341,010,90738,934Jan 29 12:51 PM
WAREHAM JOHN PDirectorJan 26Sale102.2525,9342,651,83513,000Jan 29 12:51 PM
TAYLOR RONALD RDirectorJan 24Sale99.714,885487,08321,751Jan 25 12:53 PM